Cardiovascular medical devices maker SMT has appointed Bhargav Kotadia as Chief Executive Officer and Jose Calle Gordo as Chairman, effective April 1, 2025.
Jose Calle Gordo
Kotadia, the second generation of the promoter family, takes over from Ganesh Sabat, who has played a key role in the growth of Gujarat-based SMT (Sahajanand Medical Technologies) as a medical device company over the last 12 years.
The promoters hold about 45 per cent of the company, while Morgan Stanley Private Equity and Samara Capital hold about 49 per cent, an industry insider said, adding that the company plans to pursue an IPO.
Sabat’s leadership has helped expand SMT’s global footprint, strengthen its innovation pipeline, and foster a high-performance culture, a note from the company said.
Dhirajlal Kotadia, SMT Founder and Chairman, will become Chairman Emeritus as Jose Calle Gordo assumes the role of Chairman, in an effort to drive SMT’s next phase of growth. Bhargav Kotadia has been associated with SMT for about 12 years, playing a key role in its expansion and innovation plans. The company specializes in drug-eluting stents and structural heart disease solutions, operating in over 80 countries.
